ZA953392B - New pharmaceutical dosage form for transdermal administration - Google Patents

New pharmaceutical dosage form for transdermal administration

Info

Publication number
ZA953392B
ZA953392B ZA953392A ZA953392A ZA953392B ZA 953392 B ZA953392 B ZA 953392B ZA 953392 A ZA953392 A ZA 953392A ZA 953392 A ZA953392 A ZA 953392A ZA 953392 B ZA953392 B ZA 953392B
Authority
ZA
South Africa
Prior art keywords
dosage form
pharmaceutical dosage
transdermal administration
new pharmaceutical
active agent
Prior art date
Application number
ZA953392A
Inventor
Philippe Laurent
Original Assignee
Lafon Labor
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lafon Labor filed Critical Lafon Labor
Publication of ZA953392B publication Critical patent/ZA953392B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Nutrition Science (AREA)
  • Materials Engineering (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Compsn. designed to form a film on the skin for transdermal admin. of an active agent, comprises: a) a lipophilic active agent, b) 5-60 wt.% of a silicone-based adhesive polymer compsn. c) 0-25 wt.% of an absorption promoter, and d) 25-95 wt.% of a volatile solvent.
ZA953392A 1994-04-29 1995-04-26 New pharmaceutical dosage form for transdermal administration ZA953392B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9405272A FR2719220A1 (en) 1994-04-29 1994-04-29 New galenic form for transdermal administration.

Publications (1)

Publication Number Publication Date
ZA953392B true ZA953392B (en) 1996-10-28

Family

ID=9462709

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA953392A ZA953392B (en) 1994-04-29 1995-04-26 New pharmaceutical dosage form for transdermal administration

Country Status (16)

Country Link
EP (1) EP0679392B1 (en)
JP (1) JP2740465B2 (en)
KR (1) KR100233770B1 (en)
AT (1) ATE210430T1 (en)
AU (1) AU680731B2 (en)
CA (1) CA2148112C (en)
DE (1) DE69524470T2 (en)
DK (1) DK0679392T3 (en)
ES (1) ES2169746T3 (en)
FR (1) FR2719220A1 (en)
HK (1) HK1008658A1 (en)
HU (1) HU221599B (en)
NZ (1) NZ272014A (en)
PT (1) PT679392E (en)
TW (1) TW448050B (en)
ZA (1) ZA953392B (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2740038B1 (en) * 1995-10-20 1998-01-02 Lafon Labor COMPOSITION FOR TRANSDERMAL ADMINISTRATION
KR20000052769A (en) * 1996-10-24 2000-08-25 데이비드 엠 모이어 Compositions for reducing odor on skin
US5968919A (en) * 1997-10-16 1999-10-19 Macrochem Corporation Hormone replacement therapy drug formulations for topical application to the skin
DE19830732B4 (en) * 1998-07-09 2008-11-13 Lts Lohmann Therapie-Systeme Ag Composition containing at least one substance influencing blood lipid levels and its use
US6512072B1 (en) 2000-06-12 2003-01-28 Dow Corning Corporation Fast cure film forming formulation
FR2827764B1 (en) * 2001-07-27 2005-08-19 Oreal COMPOSITION, IN PARTICULAR COSMETIC, CONTAINING A STEROID AND A GLYCOL
CA2543577A1 (en) * 2003-11-21 2005-06-16 Galderma Research & Development, S.N.C. Sprayable composition for the administration of vitamin d derivatives
FR2867682B1 (en) * 2004-03-22 2009-06-05 Galderma Res & Dev ANHYDROUS PHARMACEUTICAL COMPOSITION COMPRISING A SILICONE AGENT AND A SOLUBILIZED ACTIVE INGREDIENT.
FR2871695B1 (en) * 2004-06-17 2008-07-04 Galderma Sa PHARMACEUTICAL COMPOSITION COMPRISING A SILICONE AGENT AND TWO SOLUBILIZED ACTIVE INGREDIENTS
CA2567636A1 (en) * 2004-06-17 2005-12-29 Galderma S.A. Composition for the treatment of psoriasis comprising a silicone agent, a corticosteroid and vitamin d or a derivative thereof
FR2887150B1 (en) * 2005-06-17 2007-08-03 Galderma Res & Dev PHARMACEUTICAL COMPOSITION COMPRISING AN ORGANOPOLYSILOXANE ELASTOMER AND A SOLUBILIZED ACTIVE INGREDIENT
FR2909284B1 (en) * 2006-11-30 2012-09-21 Galderma Sa NOVEL VASELIN-FREE OINTMENTAL COMPOSITIONS COMPRISING VITAMIN D DERIVATIVE AND POSSIBLY STEROID ANTI-INFLAMMATORY
US10265265B2 (en) 2007-03-15 2019-04-23 Drug Delivery Solutions Limited Topical composition
EP2008651A1 (en) 2007-06-26 2008-12-31 Drug Delivery Solutions Limited A bioerodible patch
BR112013023458B1 (en) 2011-03-14 2020-04-07 Drug Delivery Solutions Ltd ophthalmic composition, and method for making the ophthalmic composition
US20130323332A1 (en) * 2012-05-31 2013-12-05 Sherry May Raymond-Coblantz Hand and body moisturizing serum
EP3542788A1 (en) 2018-03-19 2019-09-25 MC2 Therapeutics Limited Topical composition comprising calcipotriol and betamethasone dipropionate

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3836647A (en) * 1970-10-22 1974-09-17 Dow Corning Wash-resistant skin preparation
DE2140491A1 (en) * 1971-08-12 1973-02-22 Pawlowa Bactericidal compsns - contg a quaternary base, a filmogenic polymer and a solvent
US4584192A (en) * 1984-06-04 1986-04-22 Minnesota Mining & Manufacturing Company Film-forming composition containing an antimicrobial agent and methods of use
EP0289900A1 (en) * 1987-04-30 1988-11-09 Abbott Laboratories Topical antibacterial compositions
JPH02145512A (en) * 1988-11-26 1990-06-05 Shin Etsu Chem Co Ltd External preparation of film forming type
IN172390B (en) * 1989-07-18 1993-07-10 Ethicon Inc
EP0409383B1 (en) * 1989-07-21 1994-04-06 Izhak Blank Estradiol compositions and methods for topical applications
TW247878B (en) * 1991-07-02 1995-05-21 Takeda Pharm Industry Co Ltd
GB9114346D0 (en) * 1991-07-03 1991-08-21 Dow Corning Sa A method of accelerating drug permeation
EP0560014A1 (en) * 1992-03-12 1993-09-15 Atrix Laboratories, Inc. Biodegradable film dressing and method for its formation

Also Published As

Publication number Publication date
FR2719220A1 (en) 1995-11-03
HU221599B (en) 2002-11-28
ES2169746T3 (en) 2002-07-16
KR950028767A (en) 1995-11-22
DK0679392T3 (en) 2002-04-08
DE69524470T2 (en) 2002-05-23
PT679392E (en) 2002-05-31
EP0679392B1 (en) 2001-12-12
HU9501245D0 (en) 1995-06-28
NZ272014A (en) 1997-05-26
FR2719220B1 (en) 1997-02-14
KR100233770B1 (en) 1999-12-01
TW448050B (en) 2001-08-01
AU680731B2 (en) 1997-08-07
AU1767595A (en) 1995-11-16
JP2740465B2 (en) 1998-04-15
DE69524470D1 (en) 2002-01-24
CA2148112A1 (en) 1995-10-30
EP0679392A1 (en) 1995-11-02
HUT75251A (en) 1997-05-28
ATE210430T1 (en) 2001-12-15
HK1008658A1 (en) 1999-05-14
JPH0859456A (en) 1996-03-05
CA2148112C (en) 2001-01-30

Similar Documents

Publication Publication Date Title
ZA953392B (en) New pharmaceutical dosage form for transdermal administration
GR80327B (en) Means for transdermic application of active drug substances
DK0737066T3 (en) Transdermal device containing polyvinylpyrrolidone as solubility enhancer
PT86426A (en) A RESILIENT DEVICE FOR THE ADMINISTRATION OF A TRANSDERMMIC DRUG, AND DEVICES USING ALCANODIOUS FATTY ACIDS AS ESTIMULATORS OF PERCUTANEAL ABSORPTION
DE69214938D1 (en) AGENTS FOR TOPICAL ADMINISTRATION OF ACTIVE SUBSTANCES
HU896546D0 (en) Transdermally usable medical preparations containing gestoden
AU678197B2 (en) Percutaneous administration patch medicine
AU2467788A (en) Device for administering an active agent to the skin or mucosa
AU5022593A (en) Prodrugs, their preparation and use as pharmaceuticals
ZA946698B (en) Medical device for the administration of active ingredients or drugs at very low doses particularly homeopathic drugs
DE59309714D1 (en) Pharmaceutical and / or cosmetic preparation
DE69228674D1 (en) Nonsteroidal anti-inflammatory drug and decongestir containing ophthalmic drug composition
CA2235346A1 (en) Composition for transdermal delivery